Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Omadacycline Tosilate for Injection

Approval Number

国药准字H20210050

Company再鼎医药（上海）有限公司

Registration Date

December 14, 2021

Drug Information

Generic Name

注射用甲苯磺酸奥马环素

Trade Name

纽再乐

Dosage Form

注射剂

Strength

0.1g（按C29H40N4O7计）

Drug Type

化学药品

Registration Date

December 14, 2021

Company Information

Applicant Company

Company Name再鼎医药（上海）有限公司

Company Address

中国（上海）自由贸易试验区金科路4560号1号楼南楼4层

Manufacturing Company

Company Name浙江海正药业股份有限公司

Company Address

浙江省杭州市富阳区胥口镇海正路10号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

注射用甲苯磺酸奥马环素 - NMPA 批准文号 | MedPath